As many as six companies including Aptus Value Housing Finance, CarTrade Tech, and Supriya Lifescience have received capital markets regulator Sebi's go-ahead to float initial share sales.
The other firms that received the regulator's nod are-- Krsnaa Diagnostics, Vijaya Diagnostic Centre, and Ami Organics.
The six firms, which had filed their respective preliminary IPO papers with the markets regulator between May and June, obtained their observations during July 19-23, an update with Sebi showed on Monday.
Aptus Value's initial public offer (IPO) comprises a fresh issue of equity shares aggregating to Rs 500 crore and an offer for sale of up to 64,590,695 equity shares by the promoter and existing shareholders, draft red herring prospectus (DRHP) showed.
Proceeds from the fresh issue will be utilized towards augmenting the company's capital base and meeting future growth requirements.
According to merchant banking sources, the IPO is expected to fetch Rs 2,600-3,000 crore.
Online auto classifieds platform CarTrade Tech IPO will be entirely an offer for sale (OFS) of 12,354,811 equity shares.
Among the investors participating in the OFS are CMDB II (16.07 lakh equity shares), Highdell Investment Ltd (53.79 lakh shares), Macritchie Investments Pte Ltd (35.68 lakh shares), Springfield Venture International (11.24 lakh shares), and Bina Vinod Sanghi (1.83 lakh shares).
Currently, CMDB II holds an 11.93 percent stake in CarTrade, Highdell Investment owns 34.44 percent stake, MacRitche Investment has 26.48 per cent shareholding, and Springfield Venture International holds a 7.09 percent stake in the company.
No comments:
Post a Comment